bullous pemphigoid

JDD September Issue Highlights | Special Focus: Aesthetic Treatments
by NEXT STEPS IN DERM TEAM on
The September issue of the Journal of Drugs in Dermatology (JDD) focuses on aesthetic treatments and features original articles exploring topics such as reconstruction of the glabella and nasal root, perioral rejuvenation with high molecular weight HA and amino acid treatment, blue light and skin health, and many more.  Check out this month’s issue highlights straight from the JDD Editor’s d …
JDD August Issue Highlights | Special Focus: Psoriasis
psoriasis
by NEXT STEPS IN DERM TEAM on
The August issue of the Journal of Drugs in Dermatology (JDD) focuses on Psoriasis and features mix of original articles, editorials, and case reports. Among many of the topics explored in this issue are treatment of scalp psoriasis, nail psoriasis, respiratory tract infections in patients using biologics for hidradenitis suppurativa, classification of actinic keratosis, lichen planus pigmentosus …
JDD Issue Highlights | February 2022
psoriasis
by NEXT STEPS IN DERM TEAM on
The February 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from psoriasis and actinic keratoses to artificial intelligence in dermatology and disparities in telemedicine satisfaction, we share this month’s issue highlights straight from the JDD Editor’s desk: Early Response is Associ …
It’s Mnemonic Monday! Subepidermal and pauci-inflammatory disorders
Subepidermal and pauci-inflammatory disorders in dermatopathology
by NEXT STEPS IN DERM TEAM on
On this Mnemonic Monday, we challenge you to remember the list of subepidermal and pauci-inflammatory disorders in dermatopathology: Porphyria cutanea tarda (PCT) Epidermolysis bullousa acquisita (EBA) Toxic epidermal necrolysis/Stevens-Johnson syndrome (TEN/SJS) Bullous pemphigoid Cicatricial pemphigoid Dermatitis herpetiformis Bullous lupus erythematosus (think “SLE”) Linear IgA bu …
Dupilumab Therapeutic Cheat Sheet
Dupilumab
by Azam Qureshi, MD on
Atopic dermatitis (AD) is a common skin condition characterized by pruritus and occurs as a result of factors related to impaired skin barrier and immune response, as well as environmental and infectious agents. Patients with poor control on topical therapy are looking for safe and effective systemic treatments. We continue our series, Therapeutic Cheat Sheet, with a closer look at dupilumab, whic …